Alpine Woods Capital Investors’s Allergan plc AGN Stock Holding History

Alpine Woods Capital Investors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,500	Closed	-$250K	–	272
2018 Q2	$250K	Sell	1,500 -66,300	-98%	-$10.6M	0.05%	206
2018 Q1	$11.4M	Hold	67,800	–	–	0.61%	66
2017 Q4	$11.1M	Buy	67,800 +28,250	+71%	+$5.07M	0.55%	66
2017 Q3	$8.11M	Buy	39,550 +33,800	+588%	+$7.86M	0.41%	88
2017 Q2	$1.4M	Buy	5,750 +1,000	+21%	+$235K	0.07%	207
2017 Q1	$1.14M	Sell	4,750 -2,050	-30%	-$477K	0.06%	239
2016 Q4	$1.43M	Sell	6,800 -3,033	-31%	-$628K	0.08%	201
2016 Q3	$2.27M	Sell	9,833 -100	-1%	-$24.4K	0.13%	169
2016 Q2	$2.29M	Buy	9,933 +5,000	+101%	+$1.15M	0.14%	161
2016 Q1	$1.32M	Hold	4,933	–	–	0.08%	211
2015 Q4	$1.54M	Sell	4,933 -5,250	-52%	-$1.56M	0.08%	202
2015 Q3	$2.77M	Hold	10,183	–	–	0.15%	149
2015 Q2	$3.09M	Buy	10,183 +6,500	+176%	+$1.94M	0.16%	148
2015 Q1	$1.1M	Buy	+3,683	New	+$1.05M	0.06%	247

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Alpine Woods Capital Investors's AGN Position: Q3 2018 in Review

Alpine Woods Capital Investors sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 1,500 shares — an estimated $250K sold.

Alpine Woods Capital Investors first reported a position in AGN in Q1 2015 and held it in 14 quarters. The position peaked at $11.4M in Q1 2018. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

Alpine Woods Capital Investors reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
Alpine Woods Capital Investors sold 1,500 Allergan plc shares in Q3 2018, an estimated $250K.
Alpine Woods Capital Investors first reported a position in Allergan plc in Q1 2015 and held it in 14 quarters.
Alpine Woods Capital Investors's Allergan plc position peaked at $11.4M in Q1 2018.
1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Alpine Woods Capital Investors's 13F filing for Q3 2018, filed 8 Nov 2018.